U.S. Antiemetics Drugs Market Size & Outlook, 2024-2030
Related Markets
U.S. antiemetics drugs market highlights
- The U.S. antiemetics drugs market generated a revenue of USD 2,498.0 million in 2023 and is expected to reach USD 3,419.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.7% from 2024 to 2030.
- In terms of segment, serotonin-receptor antagonists was the largest revenue generating drug type in 2023.
- Serotonin-Receptor Antagonists is the most lucrative drug type segment registering the fastest growth during the forecast period.
Antiemetics drugs market data book summary
| Market revenue in 2023 | USD 2,498.0 million |
| Market revenue in 2030 | USD 3,419.6 million |
| Growth rate | 4.7% (CAGR from 2024 to 2030) |
| Largest segment | Serotonin-receptor antagonists |
| Fastest growing segment | Serotonin-Receptor Antagonists |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Other Drug Types (Antihistamines, Cannabinoids, Glucocorticoids) |
| Key market players worldwide | Pfizer Inc, Cipla Ltd DR, Merck KGaA, Eagle Pharmaceuticals Inc, Johnson & Johnson, GSK PLC ADR, Astellas Pharma Inc, Viatris Inc, Baxter International Inc, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.3% of the global antiemetics drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. antiemetics drugs market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 373.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antiemetics Drugs Market Scope
Antiemetics Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Glenmark Pharmaceuticals | View profile | 10001+ | Andheri, Maharashtra, India, Asia | http://www.glenmarkpharma.com |
| Eagle Pharmaceuticals Inc | View profile | 134 | 50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ, United States, 07677 | http://www.eagleus.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
U.S. antiemetics drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiemetics drugs market will help companies and investors design strategic landscapes.
Serotonin-receptor antagonists was the largest segment with a revenue share of 31.14% in 2023. Horizon Databook has segmented the U.S. antiemetics drugs market based on serotonin-receptor antagonists, anticholinergics, dopamine receptor antagonists, neurokinin receptor antagonists, other drug types (antihistamines, cannabinoids, glucocorticoids) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. antiemetics drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. antiemetics drugs market databook
-
Our clientele includes a mix of antiemetics drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. antiemetics drugs market , including forecasts for subscribers. This country databook contains high-level insights into U.S. antiemetics drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. antiemetics drugs market size, by drug type, 2018-2030 (US$M)
U.S. Antiemetics Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
